A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys

Lancet Diabetes and Endocrinology,The - Tập 3 - Trang 339-355 - 2015
Kaveh Hajifathalian1,2, Peter Ueda1, Yuan Lu1, Mark Woodward3,4,5, Alireza Ahmadvand6,7,8, Carlos A Aguilar-Salinas9, Fereidoun Azizi10, Renata Cifkova11, Mariachiara Di Cesare6,7, Louise Eriksen12, Farshad Farzadfar8, Nayu Ikeda13, Davood Khalili10, Young-Ho Khang14, Vera Lanska15, Luz León-Muñoz16,17, Dianna Magliano18, Kelias P Msyamboza19, Kyungwon Oh20, Fernando Rodríguez-Artalejo16,17
1Department of Global Health and Population, Harvard School of Public Health, Boston, MA, USA
2Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA
3The George Institute for Global Health, Nuffield Department of Population Health, University of Oxford, Oxford, UK
4The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia
5Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA
6MRC-PHE Centre for Environment and Health, Imperial College London, London, UK
7Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
8Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
9Department of Endocrinology and Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
10Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
11Department of Preventive Cardiology, Thomayer Teaching Hospital, Prague, Czech Republic
12National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark
13Center for International Collaboration and Partnership, National Institute of Health and Nutrition, Tokyo, Japan
14Institute of Health Policy and Management, Seoul National University College of Medicine, Seoul, South Korea
15Statistical Unit, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
16Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid/IdiPaz, Madrid, Spain
17CIBER of Epidemiology and Public Health, Madrid, Spain
18Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia
19WHO, Malawi Country Office, Lilongwe, Malawi
20Division of Health and Nutrition Survey, Korea Centers for Disease Control and Prevention, Cheongwon-gun, South Korea

Tài liệu tham khảo

Jackson, 2005, Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk, Lancet, 365, 434, 10.1016/S0140-6736(05)70240-3 2014, Joint British Societies' consensus recommendations for the prevention of cardiovascular disease, Heart, 100, ii1, 10.1136/heartjnl-2014-305693 2007 Stone, 2013, 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 63, 2889, 10.1016/j.jacc.2013.11.002 2014 Lim, 2007, Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs, Lancet, 370, 2054, 10.1016/S0140-6736(07)61699-7 2013 D'Agostino, 2001, Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation, JAMA, 286, 180, 10.1001/jama.286.2.180 Conroy, 2003, Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project, Eur Heart J, 24, 987, 10.1016/S0195-668X(03)00114-3 Goff, 2014, 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Circulation, 129, S49, 10.1161/01.cir.0000437741.48606.98 Singh, 2013, The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis, PLoS One, 8, e65174, 10.1371/journal.pone.0065174 Woodward, 2005, A comparison of the associations between risk factors and cardiovascular disease in Asia and Australasia, Eur J Cardiovasc Prev Rehabil, 12, 484, 10.1097/01.hjr.0000170264.84820.8e Yusuf, 2004, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, Lancet, 364, 937, 10.1016/S0140-6736(04)17018-9 Cook, 2012, Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative, Circulation, 125, 1748, 10.1161/CIRCULATIONAHA.111.075929 Neuhauser, 2005, A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination Survey 1998, Eur J Cardiovasc Prev Rehabil, 12, 442, 10.1097/01.hjr.0000183909.52118.9f Liu, 2004, Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study, JAMA, 291, 2591, 10.1001/jama.291.21.2591 Khalili, 2012, Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study, Am J Epidemiol, 176, 177, 10.1093/aje/kws204 Wu, 2006, Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults, Circulation, 114, 2217, 10.1161/CIRCULATIONAHA.105.607499 Suka, 2001, Application of the updated Framingham risk score to Japanese men, Hypertens Res, 24, 685, 10.1291/hypres.24.685 Bhopal, 2005, Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data, J Public Health (Oxf), 27, 93, 10.1093/pubmed/fdh202 Sans, 2007, Calibrating the SCORE cardiovascular risk chart for use in Spain, Rev Esp Cardiol, 60, 476, 10.1016/S0300-8932(07)75064-9 Simmonds, 2012, Risk estimation versus screening performance: a comparison of six risk algorithms for cardiovascular disease, J Med Screen, 19, 201, 10.1258/jms.2012.012076 Mendis, 2007, World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries, J Hypertens, 25, 1578, 10.1097/HJH.0b013e3282861fd3 Moran, 2014, The global burden of ischemic heart disease in 1990 and 2010: the global burden of disease 2010 study, Circulation, 129, 1493, 10.1161/CIRCULATIONAHA.113.004046 Yano, 1982, Glucose intolerance and nine-year mortality in Japanese men in Hawaii, Am J Med, 72, 71, 10.1016/0002-9343(82)90580-0 Farzadfar, 2011, National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants, Lancet, 377, 578, 10.1016/S0140-6736(10)62038-7 2007, Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths, Lancet, 370, 1829, 10.1016/S0140-6736(07)61778-4 Lawes, 2003, Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysis, Hypertension, 42, 69, 10.1161/01.HYP.0000075083.04415.4B Peters, 2014, Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes, Lancet, 383, 1973, 10.1016/S0140-6736(14)60040-4 Huxley, 2011, Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies, Lancet, 378, 1297, 10.1016/S0140-6736(11)60781-2 Harrell, 1996, Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors, Stat Med, 15, 361, 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4 2013 Smolina, 2012, Incidence and 30-day case fatality for acute myocardial infarction in England in 2010: national-linked database study, Eur J Public Health, 22, 848, 10.1093/eurpub/ckr196 Degano, 2013, Epidemiology of acute coronary syndromes in Spain: estimation of the number of cases and trends from 2005 to 2049, Rev Esp Cardiol, 66, 472 Feigin, 2009, Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review, Lancet Neurol, 8, 355, 10.1016/S1474-4422(09)70025-0 Mathers, 2004 Hammar, 2001, A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden, Int J Epidemiol, 30, S30, 10.1093/ije/30.suppl_1.S30 Krumholz, 2014, Trends in hospitalizations and outcomes for acute cardiovascular disease and stroke, 1999–2011, Circulation, 130, 966, 10.1161/CIRCULATIONAHA.113.007787 Yusuf, 2014, Cardiovascular risk and events in 17 low-, middle-, and high-income countries, N Engl J Med, 371, 818, 10.1056/NEJMoa1311890 Cooney, 2010, Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future?, Circulation, 122, 300, 10.1161/CIRCULATIONAHA.109.852756 Matheny, 2011 McGorrian, 2011, Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score, Eur Heart J, 32, 581, 10.1093/eurheartj/ehq448 2009, Measures to assess the prognostic ability of the stratified Cox proportional hazards model, Stat Med, 28, 389, 10.1002/sim.3378 2004, vols 2 and 2 Gregg, 2005, Secular trends in cardiovascular disease risk factors according to body mass index in US adults, JAMA, 293, 1868, 10.1001/jama.293.15.1868 Berry, 2012, Lifetime risks of cardiovascular disease, N Engl J Med, 366, 321, 10.1056/NEJMoa1012848 Hogerzeil, 2013, Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration, Lancet, 381, 680, 10.1016/S0140-6736(12)62128-X Yusuf, 2011, Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey, Lancet, 378, 1231, 10.1016/S0140-6736(11)61215-4